Back to Search
Start Over
Protective effect of a new biomaterial against the development of experimental osteoarthritis lesions in rabbit: a pilot study evaluating the intra-articular injection of alginate-chitosan beads dispersed in an hydrogel.
- Source :
-
Osteoarthritis and cartilage [Osteoarthritis Cartilage] 2013 Aug; Vol. 21 (8), pp. 1099-107. Date of Electronic Publication: 2013 May 13. - Publication Year :
- 2013
-
Abstract
- Objective: This study aimed to evaluate the structural benefit of a new biomaterial composed of alginate-chitosan (AC) beads dispersed in a hydrogel (H) derived from chitosan on the development of osteoarthritis (OA) in rabbit.<br />Design: OA was induced by the surgical transection of the anterior cruciate ligament in rabbits. Animals received a single intra-articular injection (900 μl) of AC beads in H hydrogel, H hydrogel alone or saline a week after surgery. OA development was followed by X-rays. Blood samples were collected throughout the study to measure biological markers (Prostaglandins E2 - PGE2 and C reactive protein - CRP). Macroscopic observation and histological evaluation of articular cartilage and synovial membrane were performed 6 weeks after surgery.<br />Results: AC beads in H hydrogel prevented from the development of OA based on the reduction of the Kellgren & Lawrence (K&L) score. It also significantly reduced the histological score of cartilage lesion severity. This effect was homogenous on every joint compartment. It was due to a significant effect on cartilage structure and cellularity scores. The injection of AC beads in H hydrogel also tended to reduce the synovial membrane inflammation. No significant variation of biological markers was noted.<br />Conclusions: The present pilot study provides interesting and promising results for the use of AC beads in H hydrogel in animal. It indeed prevented the development of OA cartilage lesions without inflammatory signs. The potencies of this biomaterial to protect OA joint should be further documented. It could then represent a new alternative for viscosupplementation in human OA management.<br /> (Copyright © 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.)
- Subjects :
- Alginates therapeutic use
Animals
Arthritis, Experimental diagnostic imaging
Arthritis, Experimental pathology
Biomarkers blood
C-Reactive Protein metabolism
Cartilage, Articular pathology
Chitosan therapeutic use
Dinoprostone blood
Drug Evaluation, Preclinical methods
Glucuronic Acid administration & dosage
Glucuronic Acid therapeutic use
Hexuronic Acids administration & dosage
Hexuronic Acids therapeutic use
Hydrogel, Polyethylene Glycol Dimethacrylate
Inflammation Mediators metabolism
Injections, Intra-Articular
Microspheres
Osteoarthritis diagnostic imaging
Osteoarthritis pathology
Pilot Projects
Rabbits
Radiography
Synovial Membrane pathology
Viscosupplementation methods
Viscosupplements therapeutic use
Alginates administration & dosage
Arthritis, Experimental prevention & control
Chitosan administration & dosage
Osteoarthritis prevention & control
Viscosupplements administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 1522-9653
- Volume :
- 21
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Osteoarthritis and cartilage
- Publication Type :
- Academic Journal
- Accession number :
- 23680875
- Full Text :
- https://doi.org/10.1016/j.joca.2013.04.017